Most recent posts

  XML Feeds

Search

« Essential Health Benefits Report ReleasedFDA Approves Combo Diabetes-Cholesterol Drug »

Task Force Expected To Recommend Against PSAs

10/10/11

  01:07:45 pm, by MedBen5   , 198 words,  
Categories: News, Wellness

Task Force Expected To Recommend Against PSAs

Two years after stirring up controversy for suggesting that mammograms can wait until most women reach their 50s, the U.S. Preventive Services Task Force is now risking further backlash for a different test. CNN reports that the group will advise that men not get screened for prostate cancer.

Tomorrow, the task force will likely recommend a “D” rating for prostate specific antigen (PSA) testing, which indicates that the harms of the service outweigh its benefits. A draft copy of the report shows the test results in “small or no reduction” in prostate cancer deaths.

According to the report, 17 out of every 100 men will have prostate cancer, and only three of them will die of the disease. The remaining 14 have slower-growing cancers that will never be harmful – but in the course of treatment, those men could be rendered impotent or incontinent.

A spokesman for the Prostate Cancer Foundation called the proposed recommendation “a tremendous mistake.”

Barring a change in guidelines, MedBen will continue to follow the American Cancer Society recommendation that screening should begin at age 50 for men who are at average risk of prostate cancer, and age 45 for men at high risk of getting the disease.

No feedback yet